Dupilumab (dupilumab) is a potentially first-in-class, fully human monoclonal antibody against IL-4 receptor alpha (IL-4Ralpha) that inhibits IL-4 and IL-13 signaling and can be used in studies related to atopic dermatitis and asthma.
Purity:
99.0%
CAS Number:
[1190264-60-8]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted